Cargando…
Multicenter Clinical Evaluation of ETEST Plazomicin (PLZ) for Susceptibility Testing of Enterobacterales
Plazomicin (PLZ), brand name ZEMDRI (Cipla Therapeutics), is a novel aminoglycoside antibiotic approved by the U.S. Food and Drug Administration (FDA) for treatment of complicated urinary tract infections including pyelonephritis. ETEST® is a gradient diffusion method that represents an alternative...
Autores principales: | Blanchard, Laurine S., Van Belkum, Alex, Dechaume, Dominique, Armstrong, Thomas P., Emery, Christopher L., Ying, Yun X., Kresken, Michael, Pompilio, Marion, Halimi, Diane, Zambardi, Gilles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769719/ https://www.ncbi.nlm.nih.gov/pubmed/34757833 http://dx.doi.org/10.1128/JCM.01831-21 |
Ejemplares similares
-
1227. Plazomicin Susceptibility Testing using ETEST(®) MIC for Enterobacterales
por: Ying, Yun, et al.
Publicado: (2020) -
Multicenter Clinical Evaluation of ETEST Eravacycline for Susceptibility Testing of Enterobacteriaceae and Enterococci
por: Blanchard, Laurine S., et al.
Publicado: (2023) -
Multicenter Evaluation of the Novel ETEST Fosfomycin for Antimicrobial Susceptibility Testing of Enterobacterales, Enterococcus faecalis, and Staphylococcus Species
por: Goer, A., et al.
Publicado: (2022) -
1222. Fosfomycin Susceptibility Testing using the new ETEST(®)FO
por: Halimi, Diane, et al.
Publicado: (2020) -
Multicenter Clinical Performance Evaluation of Omadacycline Susceptibility Testing of Enterobacterales on VITEK 2 Systems
por: Csiki-Fejer, Edith, et al.
Publicado: (2023)